Literature DB >> 8237940

Helicobacter pylori is a risk factor for hepatic encephalopathy in acute alcoholic hepatitis: the ammonia hypothesis revisited. The Veterans Administration Cooperative Study Group No. 275.

G P Gubbins1, T E Moritz, L S Marsano, R Talwalkar, C J McClain, C L Mendenhall.   

Abstract

OBJECTIVE: To determine whether infection with Helicobacter pylori is a risk factor for portosystemic encephalopathy in patients with acute, moderate or severe alcoholic hepatitis.
DESIGN: Prospective, multicenter cohort study.
SETTING: Eight Veterans Affairs Hospitals. PATIENTS: A cohort of 273 male patients enrolled in a Department of Veterans Affairs Cooperative Study performed to evaluate the efficacy of oxandrolone in combination with nutritional supplementation in moderate or severe alcoholic hepatitis. MEASUREMENTS: Admission serum IgG antibody titers against H. pylori by a specific and sensitive ELISA, demographic characteristics of patients, degree of protein calorie malnutrition, presence of ascites, bilirubin level, and known risk factors for hepatic encephalopathy (gastrointestinal bleeding, azotemia, hepatorenal syndrome, infection, and severity of disease); outcome was the presence of portosystemic encephalopathy.
RESULTS: Of 188 patients with decompensated alcoholic hepatitis available for analysis, 117 (62.2%) had encephalopathy. Ninety-two (78.6%) of these were infected with H. pylori, compared with 62% of patients without encephalopathy (p = 0.013). In a step-wise regression model, H. pylori was an independent risk factor (relative risk: 2.4, 95% CI: 1.2-4.8) adjusting for ascites and protein-calorie malnutrition.
CONCLUSIONS: Patients with acute, moderate or severe alcoholic hepatitis have a high H. pylori infection rate (as determined by serology), and those infected are at higher risk for portosystemic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8237940

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  13 in total

Review 1.  Extradigestive manifestations of Helicobacter pylori infection: fact and fiction.

Authors:  G Realdi; M P Dore; L Fastame
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

2.  Liver disease and Helicobacter.

Authors:  Yu-Qin Luo; Jin-Bo Teng; Bo-Rong Pan; Xue-Yong Zhang
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

3.  Helicobacter pylori infection is not associated with subclinical hepatic encephalopathy in stable cirrhotic patients.

Authors:  I A Scotiniotis; M R Lucey; D C Metz
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

4.  Reduced stents and stent-grafts for the management of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt creation.

Authors:  David C Madoff; Michael J Wallace
Journal:  Semin Intervent Radiol       Date:  2005-12       Impact factor: 1.513

5.  Helicobacter pylori, ammonia and the brain.

Authors:  S D Taylor-Robinson; N Jackson; C Buckley
Journal:  Gut       Date:  1997-06       Impact factor: 23.059

6.  Role of cysteine proteases and protease inhibitors in gastric mucosal damage induced by ethanol or ammonia in the rat.

Authors:  L Nagy; S Kusstatscher; P V Hauschka; S Szabo
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

7.  Role of Helicobacter pylori infection in the pathogenesis of minimal hepatic encephalopathy and effect of its eradication.

Authors:  Avinash Agrawal; Alok Gupta; Mam Chandra; Sciddhartha Koowar
Journal:  Indian J Gastroenterol       Date:  2011-03-18

Review 8.  Association of Helicobacter pylori with the Risk of Hepatic Encephalopathy.

Authors:  Karn Wijarnpreecha; Supavit Chesdachai; Charat Thongprayoon; Veeravich Jaruvongvanich; Patompong Ungprasert; Wisit Cheungpasitporn
Journal:  Dig Dis Sci       Date:  2017-11-08       Impact factor: 3.199

9.  Effect of H pylori infection and its eradication on hyperammo-nemia and hepatic encephalopathy in cirrhotic patients.

Authors:  Shu-Jie Chen; Liang-Jing Wang; Qin Zhu; Jian-Ting Cai; Tao Chen; Jian-Min Si
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

10.  a-Anilinoketones, Esters and Amides: A Chemical Study.

Authors:  Amjad M Qandil; Lara I Fakhouri
Journal:  Pharmaceuticals (Basel)       Date:  2012-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.